Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9023859 | Composition and method for treating or preventing skeletal muscle fibrosis | Mark Pines | 2015-05-05 |
| 8410120 | Composition and method for treating or preventing skeletal muscle fibrosis | Mark Pines | 2013-04-02 |
| RE39574 | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies | Mark Pines, Israel Vlodavsky, Hua-Quan Mian | 2007-04-17 |
| RE39096 | Treatment of skin disorders | Mark Pines | 2006-05-16 |
| 6562829 | Treatment of hepatic cirrhosis | Mark Pines | 2003-05-13 |
| RE37828 | Treatment and prevention of adhesions | Mark Pines | 2002-09-03 |
| 6420371 | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies | Mark Pines, Israel Vlodavsky | 2002-07-16 |
| 6211188 | Treatment of skin disorders | Mark Pines | 2001-04-03 |
| 6159488 | Intracoronary stents containing quinazolinone derivatives | Eli Hazum, Ehud Geller, Shimon Slavin, Israel Vlodavsky, Mark Pines | 2000-12-12 |
| 6090814 | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization | Shimon Slavin, Israel Vlodavsky, Mark Pines | 2000-07-18 |
| 6028075 | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies | Mark Pines, Israel Vlodavsky, Hua Miao | 2000-02-22 |
| 5998422 | Quinazolinone-containing pharmaceutical compositions and methods for the use thereof | Shimon Slavin, Israel Vlodavsky, Mark Pines | 1999-12-07 |
| 5891879 | Quinazolinone-containing pharmaceutical compositions and methods for the use thereof | Shimon Slavin, Israel Vlodavsky, Mark Pines | 1999-04-06 |
| 5852024 | Treatment and prevention of adhesions | Mark Pines | 1998-12-22 |
| 5449678 | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | Mark Pines, Shimon Slavin | 1995-09-12 |
| 5041289 | Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells | Joseph H. Phillips, Lewis L. Lanier | 1991-08-20 |